CLINICAL CHARACTERISTICS AND RISK FACTORS OF PEOPLE WITH NEWLY DIAGNOSED TYPE 2 DIABETES AND WITH DYSLIPIDEMIA

Đình Tùng Đỗ1,, Văn Bình Tạ 2, cs
1 Xanh Pon hospital
2 Hanoi medicla university

Main Article Content

Abstract

The study aimed to find the answers to insulin resistance in people with type 2 diabetes with dyslipidemia in Vietnam to provide better knowledge of control and treatment. 163 patients with type 2 diabetes diagnosed for the first time, among them 95 (58%) patients with dyslipidemia, and 53 subjects were recruited as the control. Data collection through clinical examination, blood lipid, insulin, C-peptide tests. The results showed that the mean age at diagnosis of diabetes was 53.8 ± 12.2 (53.0 ± 13.6 for female; 54.6 ± 10.7 for male). The index of insulin, C-peptide, TC, TG, and LDL-C of the group of diabetes without dyslipidemia wá significantly lower than those with dyslipidemia. Thus, insulin resistance and dyslipidemia should be considered during treatment.

Article Details

References

1. Tạ Văn Bình (2004), Bệnh béo phì. Nhà xuất bản Y học.
2. Tạ Văn Bình (2006), Bệnh đái tháo đường- Tăng glucose máu. Nhà xuất bản Y học.
3. Lưu Cảnh Toàn (2006), Nghiên cứu tình trạng kháng insulin và chức năng tế bào β ở bệnh nhân ĐTĐ týp 2 có tăng huyết áp. Luận văn thạc sỹ y học - Học viện Quân y.
4. American Diabetes Association (1997), Report of the expert committee on the diagnosis and classification of Diabetes Mellitus. Diabetes care, p.1184-1195.
5. Foster Daniel W. (1991), Harrison’s principle of internal medicine. International edition V2, 1991, p.1739-1757.
6. John K. Davidson, Clinical Diabetes Mellitus. Third Edition. A problem oriented opproach, p.354-355.
7. Matthews (2001), Insulin resistance and beta-cell function – a clinical perspective, Diabetes. Obesity and Metabolism. 3 (Suppl. 1): S28-S33.
8. Zierath J.R., Handberg A., Tally M., Wallberg- Henriksson H. (1996), C-peptid stimulates glucose transport in isolated skeletal muscle independent of insulin receptor and tyrosin kinase activation. Diabetologia, 39:306-313.
9. Zimmet P. (2001), Epidemiology, Evidence for prevention typ2 diabetes. The epidemiology of diabetes mellitus, p.41.